Butofilolol

Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.

Butofilolol
Clinical data
Other namesCM-6805
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.055.892
Chemical and physical data
FormulaC17H26FNO3
Molar mass311.392 g/mol g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

References

  1. Houin, G; Barre, J; Jeanniot, JP; Ledudal, P; Cautreels, W; Tillement, JP (1984). "Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man". International Journal of Clinical Pharmacology Research. 4 (3): 175–83. PMID 6149195.
  2. Toussain, P; Gay, G; Debry, G (1983). "Long-term hypotensive treatment by butofilolol". Annales de Cardiologie et d'Angeiologie. 32 (4): 277–83. PMID 6412614.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.